US Patent 8383367 IL-21 variant nucleic acids
Patent 8383367 was granted and assigned to Novo Nordisk on February, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 19, 2011
Date of Patent
February 26, 2013
Patent Application Number
13236163
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8383367 IL-21 variant nucleic acids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.